Open main menu
Home
Random
Recent changes
Special pages
Community portal
Preferences
About Wikipedia
Disclaimers
Incubator escapee wiki
Search
User menu
Talk
Dark mode
Contributions
Create account
Log in
Editing
Hibernating myocardium
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
{{Short description|State when some segments of the myocardium exhibit abnormalities of contractile function}} In [[cardiology]], '''hibernating myocardium''' is a state when some segments of the [[myocardium]] exhibit abnormalities of contractile function.<ref name="pmid9664095">{{cite journal |vauthors=Wijns W, Vatner SF, Camici PG |title=Hibernating myocardium |journal=N. Engl. J. Med. |volume=339 |issue=3 |pages=173β81 |date=July 1998 |pmid=9664095 |doi= 10.1056/NEJM199807163390307|url=http://content.nejm.org/cgi/pmidlookup?view=short&pmid=9664095&promo=ONFLNS19|url-access=subscription }}</ref> These abnormalities can be visualised with [[echocardiography]], [[cardiac magnetic resonance imaging]] (CMR), nuclear medicine (PET) or [[Cardiac ventriculography|ventriculography]]. Echocardiography: A wall motion abnormality at rest which improves during a low-dose dobutamine stress test is classified as "hibernating myocardium." Low dose dobutamine stimulates contractile function and thus helps to predict functional recovery after revascularization. Cardiac magnetic resonance: The most frequently used MR [[contrast agent]]s based on Gd-chelates accumulate in the extracellular space which is increased in scarred myocardium. This leads to a signal increase which can be visualised with the "late gadolinium enhancement technique." This is probably the most accurate way to visualise scarred myocardium. An alternative (or additional) technique with CMR is the use of low dose dobutamine similar to echocardiography. PET: The finding of a perfusion or metabolic mismatch between PET-FDG and PET-NH<sub>3</sub> is indicative of decreased metabolism. The wall of the affected segments is hypo-, a-, or dyskinetic.{{cn|date=February 2021}} The phenomenon is highly significant clinically because it usually manifests itself in the setting of chronic [[ischemia]], that is potentially reversible by [[Revascularization|revascularisation]] via cardiac catheterization. The regions of myocardium are still viable and can return to normal function. There develops a new steady state between myocardial blood flow (MBF) and myocardial function, MBF reduced and in consequence function is reduced too. The clinical situations where one can expect hibernating myocardium are:{{cn|date=February 2021}} * chronic stable [[Angina pectoris|angina]] * unstable angina * silent ischemia * after [[myocardial infarction|AMI]] ==See also== * [[Stunned myocardium]] * [[Myocardial scarring]] ==References== {{Reflist}} {{Heart diseases}} [[Category:Ischemic heart diseases]] {{Circulatory-disease-stub|}}
Edit summary
(Briefly describe your changes)
By publishing changes, you agree to the
Terms of Use
, and you irrevocably agree to release your contribution under the
CC BY-SA 4.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)
Pages transcluded onto the current version of this page
(
help
)
:
Template:Circulatory-disease-stub
(
edit
)
Template:Cite journal
(
edit
)
Template:Cn
(
edit
)
Template:Heart diseases
(
edit
)
Template:Reflist
(
edit
)
Template:Short description
(
edit
)